Combination therapy shows promise for leptomeningeal metastasis in breast cancer

[News]

Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted therapies, tucatinib and trastuzumab, plus the chemotherapy drug, capecitabine, may improve symptoms and extend survival in some breast cancer patients with LM.

More... (https://www.news-medical.net/news/20260318/Combination-therapy-shows-promise-for-leptomeningeal-metastasis-in-breast-cancer.aspx)